Trade Summary

1 week ago, Choo Chee Kong, serving as Dir at CytoMed Therapeutics Ltd (GDTC), purchased 200,000 shares at $1.50 per share, for a total transaction value of $300,000.00. Following this transaction, Choo Chee Kong now holds 630,324 shares of GDTC.

This purchase represents a 46.48% increase in Choo Chee Kong's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, July 25, 2026 (accepted Jul 24, 9:01 PM ET), 11 days after the trade was made.

CytoMed Therapeutics Ltd operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.